Table 2 The correlation between FOXO1 expression and clinicopathological characteristics of 125 OV patients
Characteristic | FOXO1 expression | p-value | |
|---|---|---|---|
Low (H-score < 100) | High (H-score ≥ 100) | ||
Age (n,%) | Â | Â | 0.318 |
  < 55 years | 35(62.5%) | 21(37.5%) | - |
  ≥ 55 years | 37(53.6%) | 32(46.4%) | - |
FIGO stage (n,%) | Â | Â | 0.246 |
 I-II | 29(64.4%) | 16(35.6%) | - |
 III-IV | 43(53.8%) | 37(46.2%) | - |
Pathology stage (n,%) | Â | Â | 0.155 |
 I-II | 35(64.8%) | 19(35.2%) | - |
 III | 37(52.1%) | 34(47.9%) | - |
Histology type (n,%) | Â | Â | 0.062 |
 Serous | 51(65.4%) | 27(34.6%) | - |
 Mucous | 6(4.8%) | 5(4.0%) | - |
 Endometrioid | 4(28.6%) | 10(71.4%) | - |
 Other types | 11(50.0%) | 11(50.0%) | - |
Tumor diameter (n,%) | Â | Â | 0.179 |
  < 10 cm | 32(51.6%) | 30(48.4%) | - |
  ≥ 10 cm | 40(63.5%) | 23(36.5%) | - |
Serum CA125 (n, %) | Â | Â | 0.813 |
  < 35 U/ml | 12(60.0%) | 8(40.0%) | - |
  ≥ 35 U/ml | 60(57.1%) | 45(42.9%) | - |